(Q34303121)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Genetic and structural determinants of virus neutralizing antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

R O Suara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Brock

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

N Kallewaard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F House

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J H Weitkamp

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

135-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11444379%20AND%20SRC:MED&resulttype=core&format=json

Intracellular neutralization of virus by immunoglobulin A antibodies

9 November 2019

cites work

1 reference

12 December 2020

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

12 December 2020

Rates of spontaneous mutation among RNA viruses

1 reference

12 December 2020

Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo

1 reference

12 December 2020

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

12 December 2020

Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120.

1 reference

12 December 2020

In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity

1 reference

12 December 2020

Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?

1 reference

12 December 2020

Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity

1 reference

12 December 2020

Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies

1 reference

12 December 2020

Antibody and virus: binding and neutralization

1 reference

12 December 2020

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

1 reference

12 December 2020

Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats

1 reference

12 December 2020

Host responses to respiratory virus infection and immunization.

1 reference

12 December 2020

Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein

1 reference

12 December 2020

Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization

1 reference

12 December 2020

Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virus

1 reference

12 December 2020

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

1 reference

12 December 2020

Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody

1 reference

12 December 2020

Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells

1 reference

12 December 2020

The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry

1 reference

12 December 2020

A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event

1 reference

12 December 2020

Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection

1 reference

12 December 2020

Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses

1 reference

12 December 2020

Rapid analysis of epitope-paratope interactions between HIV-1 and a 17-amino-acid neutralizing microantibody by electrospray ionization mass spectrometry

1 reference

12 December 2020

Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.

1 reference

12 December 2020

Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.

1 reference

12 December 2020

Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction

1 reference

12 December 2020

Early restriction of the human antibody repertoire

1 reference

12 December 2020

Human antibody variable region gene usage in HIV-1 infection

1 reference

12 December 2020

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

1 reference

12 December 2020

Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition

1 reference

12 December 2020

Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice

1 reference

12 December 2020

Neutralization of respiratory syncytial virus after cell attachment.

1 reference

12 December 2020

A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro

1 reference

12 December 2020

A retro-inverso miniantibody with anti-HIV activity

1 reference

12 December 2020

A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.

1 reference

12 December 2020

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines

1 reference

12 December 2020

Structural characterization of the human respiratory syncytial virus fusion protein core

1 reference

12 December 2020

Biased VH gene usage in early lineage human B cells: evidence for preferential Ig gene rearrangement in the absence of selection.

1 reference

12 December 2020

Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies

1 reference

12 December 2020

Clonal selection and learning in the antibody system

1 reference

12 December 2020

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

1 reference

12 December 2020

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

12 December 2020

Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines

1 reference

12 December 2020

IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells

1 reference

12 December 2020

Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection.

1 reference

12 December 2020

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

1 reference

12 December 2020

Immunological determinants of disease caused by respiratory syncytial virus

1 reference

12 December 2020

Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM

1 reference

12 December 2020

Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity

1 reference

12 December 2020

Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition

1 reference

12 December 2020

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

1 reference

12 December 2020